Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

JPMorgan downgrades Nufarm stock amid weak 1H24 results

EditorEmilio Ghigini
Published 05/24/2024, 04:42 AM
NFRMY
-

On Friday, JPMorgan adjusted its stance on Nufarm (OTC:NFRMY) Ltd. (ASX:NUF) (OTC: NFRMY), shifting the agricultural chemical company's stock rating from Overweight to Neutral.

The firm also set a new price target of AUD 5.50, a decrease from the previous target of AUD 6.00. The downgrade follows Nufarm's first-half financial results for 2024, which fell short of expectations due to lower pricing in the Crop Protection sector.

Nufarm's earnings before interest, taxes, depreciation, and amortization (EBITDA) were approximately 14% below JPMorgan's estimates. This shortfall was attributed to the Crop Protection segment's depressed pricing, which continued to be affected by destocking activities among growers and distributors. Despite an increase in volume, this pricing issue significantly impacted the company's gross and operating margins.

The company's financial leverage also came under scrutiny, with its gearing ratio rising to 3.6 times net debt to EBITDA, up from 2.4 times in the previous corresponding period.

However, Nufarm's management anticipates an operational improvement in the second half of 2024, with EBITDA guidance set between AUD 350 million and AUD 390 million.

If these expectations are met, along with better working capital management, the gearing ratio is expected to align with the upper end of the company's target range of 1.5 to 2.0 times by June 2024.

Management emphasized the "covenant-light" nature of Nufarm's current lending agreements during the announcement, which may offer some flexibility in meeting financial obligations.

Additionally, attention was drawn to the company's fiscal year 2026 targets, which hinge on a significant recovery in prices—estimated by management to be around 20% from current levels.

While the report acknowledged challenges in the Crop Protection market, it also recognized the potential for growth in the Seeds division. JPMorgan noted that revenue and earnings from Seeds are expected to increase as the company continues to commercialize its products and normalize trading patterns.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.